vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and WIDEPOINT CORP (WYY). Click either name above to swap in a different company.

IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $42.3M, roughly 1.1× WIDEPOINT CORP). WIDEPOINT CORP runs the higher net margin — -2.0% vs -4.8%, a 2.8% gap on every dollar of revenue. On growth, WIDEPOINT CORP posted the faster year-over-year revenue change (12.3% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-270.0K). Over the past eight quarters, WIDEPOINT CORP's revenue compounded faster (11.2% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

WidePoint Corporation is an American company based in Fairfax, Virginia that provides technology-based products and services to the government sector and commercial markets in the United States. The company holds a patent for a digital parsing tool that allows users to access accounts through a secure repository gateway, established using asymmetric authentication employed as public key infrastructure (PKI). WidePoint provides smart card identity verification, wireless expense management, pen...

IRWD vs WYY — Head-to-Head

Bigger by revenue
IRWD
IRWD
1.1× larger
IRWD
$47.7M
$42.3M
WYY
Growing faster (revenue YoY)
WYY
WYY
+59.6% gap
WYY
12.3%
-47.3%
IRWD
Higher net margin
WYY
WYY
2.8% more per $
WYY
-2.0%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$74.8M more FCF
IRWD
$74.6M
$-270.0K
WYY
Faster 2-yr revenue CAGR
WYY
WYY
Annualised
WYY
11.2%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRWD
IRWD
WYY
WYY
Revenue
$47.7M
$42.3M
Net Profit
$-2.3M
$-849.4K
Gross Margin
13.8%
Operating Margin
14.3%
-1.9%
Net Margin
-4.8%
-2.0%
Revenue YoY
-47.3%
12.3%
Net Profit YoY
-200.9%
-138.3%
EPS (diluted)
$0.01
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
WYY
WYY
Q4 25
$47.7M
$42.3M
Q3 25
$122.1M
$36.1M
Q2 25
$85.2M
$37.9M
Q1 25
$41.1M
$34.2M
Q4 24
$90.5M
$37.7M
Q3 24
$91.6M
$34.6M
Q2 24
$94.4M
$36.0M
Q1 24
$74.9M
$34.2M
Net Profit
IRWD
IRWD
WYY
WYY
Q4 25
$-2.3M
$-849.4K
Q3 25
$40.1M
$-559.2K
Q2 25
$23.6M
$-618.5K
Q1 25
$-37.4M
$-724.1K
Q4 24
$2.3M
$-356.4K
Q3 24
$3.6M
$-425.2K
Q2 24
$-860.0K
$-499.6K
Q1 24
$-4.2M
$-653.1K
Gross Margin
IRWD
IRWD
WYY
WYY
Q4 25
13.8%
Q3 25
14.6%
Q2 25
13.5%
Q1 25
14.0%
Q4 24
12.6%
Q3 24
13.6%
Q2 24
13.6%
Q1 24
13.6%
Operating Margin
IRWD
IRWD
WYY
WYY
Q4 25
14.3%
-1.9%
Q3 25
61.8%
-1.3%
Q2 25
53.2%
-1.9%
Q1 25
-70.7%
-2.4%
Q4 24
34.8%
-0.8%
Q3 24
28.0%
-1.3%
Q2 24
26.5%
-1.3%
Q1 24
14.7%
-1.9%
Net Margin
IRWD
IRWD
WYY
WYY
Q4 25
-4.8%
-2.0%
Q3 25
32.8%
-1.5%
Q2 25
27.7%
-1.6%
Q1 25
-90.9%
-2.1%
Q4 24
2.5%
-0.9%
Q3 24
4.0%
-1.2%
Q2 24
-0.9%
-1.4%
Q1 24
-5.6%
-1.9%
EPS (diluted)
IRWD
IRWD
WYY
WYY
Q4 25
$0.01
$-0.08
Q3 25
$0.23
$-0.06
Q2 25
$0.14
$-0.06
Q1 25
$-0.23
$-0.08
Q4 24
$0.03
$-0.05
Q3 24
$0.02
$-0.04
Q2 24
$-0.01
$-0.05
Q1 24
$-0.03
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
WYY
WYY
Cash + ST InvestmentsLiquidity on hand
$215.5M
$9.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$-261.8M
$11.5M
Total Assets
$396.9M
$79.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
WYY
WYY
Q4 25
$215.5M
$9.8M
Q3 25
$140.4M
$12.1M
Q2 25
$92.9M
$6.8M
Q1 25
$108.5M
$3.7M
Q4 24
$88.6M
$6.8M
Q3 24
$88.2M
Q2 24
$105.5M
Q1 24
$121.5M
Total Debt
IRWD
IRWD
WYY
WYY
Q4 25
Q3 25
$199.5M
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$199.0M
Q3 24
$198.8M
Q2 24
$198.6M
Q1 24
$398.3M
Stockholders' Equity
IRWD
IRWD
WYY
WYY
Q4 25
$-261.8M
$11.5M
Q3 25
$-264.2M
$12.2M
Q2 25
$-308.2M
$12.6M
Q1 25
$-334.1M
$13.0M
Q4 24
$-301.3M
$13.6M
Q3 24
$-311.3M
$13.8M
Q2 24
$-321.7M
$14.0M
Q1 24
$-330.5M
$14.2M
Total Assets
IRWD
IRWD
WYY
WYY
Q4 25
$396.9M
$79.8M
Q3 25
$396.1M
$70.6M
Q2 25
$342.9M
$76.6M
Q1 25
$327.2M
$71.4M
Q4 24
$350.9M
$71.6M
Q3 24
$389.5M
$56.9M
Q2 24
$395.6M
$58.6M
Q1 24
$438.8M
$54.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
WYY
WYY
Operating Cash FlowLast quarter
$74.6M
$-173.5K
Free Cash FlowOCF − Capex
$74.6M
$-270.0K
FCF MarginFCF / Revenue
156.3%
-0.6%
Capex IntensityCapex / Revenue
0.0%
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
WYY
WYY
Q4 25
$74.6M
$-173.5K
Q3 25
$47.6M
$5.9M
Q2 25
$-15.1M
$3.2M
Q1 25
$20.0M
$-3.2M
Q4 24
$15.2M
$2.4M
Q3 24
$9.9M
$1.9M
Q2 24
$33.5M
$-1.1M
Q1 24
$45.0M
$-1.6M
Free Cash Flow
IRWD
IRWD
WYY
WYY
Q4 25
$74.6M
$-270.0K
Q3 25
$47.6M
$5.9M
Q2 25
$-15.1M
$3.1M
Q1 25
$19.9M
$-3.3M
Q4 24
$2.4M
Q3 24
$9.9M
$1.8M
Q2 24
$33.4M
$-1.1M
Q1 24
$44.9M
$-1.6M
FCF Margin
IRWD
IRWD
WYY
WYY
Q4 25
156.3%
-0.6%
Q3 25
39.0%
16.4%
Q2 25
-17.7%
8.1%
Q1 25
48.4%
-9.5%
Q4 24
6.4%
Q3 24
10.8%
5.3%
Q2 24
35.4%
-3.0%
Q1 24
60.0%
-4.6%
Capex Intensity
IRWD
IRWD
WYY
WYY
Q4 25
0.0%
0.2%
Q3 25
0.0%
0.1%
Q2 25
0.0%
0.2%
Q1 25
0.1%
0.1%
Q4 24
0.0%
0.1%
Q3 24
0.0%
0.2%
Q2 24
0.1%
0.0%
Q1 24
0.1%
0.0%
Cash Conversion
IRWD
IRWD
WYY
WYY
Q4 25
Q3 25
1.19×
Q2 25
-0.64×
Q1 25
Q4 24
6.74×
Q3 24
2.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRWD
IRWD

Segment breakdown not available.

WYY
WYY

Carrier Services$26.8M63%
Managed Services$15.5M37%

Related Comparisons